Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
6.45
+0.05 (0.78%)
Oct 14, 2025, 3:44 PM EDT - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $43.44 million as of October 14, 2025. Its market cap has decreased by -71.94% in one year.
Market Cap
43.44M
Enterprise Value
-13.00M
1-Year Change
-71.94%
Ranking
Category
Stock Price
$6.45
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $43.44M, a decrease of -95.95%. That is a compound annual growth rate of -45.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 43.11M | -39.11% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |